Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Irish Drugmaker Elan to Spin Off Research Unit
Aug. 14, 2012
The decision to split the company comes hard on the heels of the failure of an experimental Alzheimer’s drug being developed with Pfizer and Johnson & Johnson, although Chief Executive Kelly Martin said it had been planned for more than a year.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing